Mangoceuticals completes first batch of mango ED products for LATAM

Mangoceuticals announces that its subsidiary, MangoRx Mexico S.A. de C.V., in conjunction with its Mexico-based pharmacy partner Emifarma S.A. de C.V, has successfully completed its first sample batch of Mango erectile dysfunction, ED, oral dissolvable tablets, ODTs, specifically to be marketed and sold in Mexico and other eligible Latin American, LATAM, countries. “This achievement marks a significant milestone in our expansion into the Mexican and Latin American markets,” stated Jacob Cohen, MangoRx’s Co-Founder and CEO. “The successful production of our first batch of Mango ED ODTs is a testament to the dedication and expertise of our team and partners. We are committed to delivering high-quality products that meet the stringent requirements set by COFEPRIS and look forward to the next steps in this process.”